Several studies have suggested that 18F-FDG PET/CT, a noninvasive molecular imaging technique to detect malignant tumors, can predict gene expression status, such as LDHA in lung cancer and HER2 in gastric cancer (20, 21). The gene discussed is ERBB2; the disease is cancer.